Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Newborn mass screening for galactosemia

S Schweitzer1

  • 1Department of Paediatric Nephrology and Metabolic Disorders, Children's Hospital, Medical School Hannover, Germany.

European Journal of Pediatrics
|January 1, 1995
PubMed
Summary

Newborn screening for galactosemia, available since 1964, is crucial for early diagnosis. Despite its rarity, mass screening ensures timely detection of galactosemia, preventing severe symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Management and wage earners: occupations and flexibilities (Lyons, 19th-20th centuries)].

Histoire, economie et societe·2007
Same author

[Patients as partners. Tumor patients and their participation in medical decisions].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2004
Same author

[Ambulant care of patients in the terminal phase of malignant tumor: answers by general practioners in Thuringia to a questionnaire].

Deutsche medizinische Wochenschrift (1946)·2003
Same author

Seventeen novel mutations that cause profound biotinidase deficiency.

Molecular genetics and metabolism·2002
Same author

Lipidation of T helper sequences from hepatitis C virus core significantly enhances T-cell activity in vitro.

Immunology·2001
Same author

Flow cytometric analysis of peptide binding to major histocampatibility complex class I for hepatitis C virus core T-cell epitopes.

Cytometry·2000

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Galactosemia is a rare genetic disorder.
  • Clinical symptoms can appear early in newborns.
  • Mass screening methods for galactosemia have existed since 1964.

Purpose of the Study:

  • To evaluate the necessity of newborn screening for galactosemia.
  • To highlight the importance of early diagnosis through mass screening.

Main Methods:

  • Review of existing mass screening protocols for galactosemia.
  • Analysis of diagnostic capabilities for galactosemia.

Main Results:

  • Newborns with galactosemia can be reliably diagnosed through mass screening.
  • Early detection is critical due to the potential for severe clinical symptoms.

Conclusions:

  • Mass screening for galactosemia is essential for timely diagnosis and management.
  • Despite differing national policies, early detection via screening is vital for affected newborns.

Related Experiment Videos